Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVERSE-HF: Aquadex System vs IV Loop Diuretics in Heart Failure and Fluid Overload
NCT05318105Terminated
- Sponsor
- Nuwellis
- Start
- Jun 2022
- Primary completion
- Oct 2025
- Countries
- 1
01
Overview
Randomised trial in heart failure (HF) and Fluid overload (2 arms), sponsored by Nuwellis. Primary endpoint: Time to first heart failure event at 30 days. Started Jun 2022; status: terminated.
02
Conditions
heart failure (HF)Fluid overload
Beyond the preview
Go deeper on NCT05318105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05318105.